FDA Dental Panel To Assess Tricalcium Phosphate Downclassification May 22
This article was originally published in The Gray Sheet
Executive Summary
A recommendation by FDA's Dental Products Panel to downclassify tricalcium phosphate granules for dental bone repair to Class II could pave the way for Bicon, Inc. to submit a 510(k) for its Biconoss bone graft